Arguably,, the biggest storyline surrounding the Minnesota Vikings this offseason and heading into the 2025 season is how the ...

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

BTIG analyst Justin Zelin reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...

Vikings safety Cam Bynum emerged as one of the team's biggest stars but faces uncertainty ahead of free agency.

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

Mike Florio and Chris Simms examine why signs are pointing to Brian Flores sticking with the Vikings for another season and how he’s been able to make something special out of the defense.

Viking Therapeutics Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -34.83%. The profit margin, also known as the revenue ratio or gross profit ...

Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at ...

The Chicago Bears have interviewed Minnesota Vikings defensive coordinator Brian Flores for their head coaching job. The ...

After the Minnesota Vikings beat the Green Bay Packers on Sunday, 27-25, in Week 17 of the NFL season, the Lions must beat the Vikings in Week 18 at Ford Field to lock up the top spot in the NFC ...

Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended Keytruda's coming loss of exclusivity can be managed.

Vikings players and coaches gather somewhere in the Twin Cities for an event they call “Fellowship Thursdays.” Kevin ...